ACA
Overvalued by 31.2% based on the discounted cash flow analysis.
Market cap | $4.24 Billion |
---|---|
Enterprise Value | $5.75 Billion |
Dividend Yield | $0.2 (0.229885057471264%) |
Earnings per Share | $1.93 |
Beta | 1 |
Outstanding Shares | 48,700,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 45.22 |
---|---|
PEG | -35.21 |
Price to Sales | 1.74 |
Price to Book Ratio | 1.85 |
Enterprise Value to Revenue | 2.24 |
Enterprise Value to EBIT | 40.6 |
Enterprise Value to Net Income | 61 |
Total Debt to Enterprise | 0.29 |
Debt to Equity | 0.71 |
No data
No data